TearSolutions
TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients.
2
Funding Rounds
$4.5m
Money raised
Overview
TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients.
Funding series
Funding Series Analysis
The company TearSolutions has raised a total of $3m in funding over 2 rounds.
Key Insights:
- TearSolutions November 2024 Series B Funding Round: $3m
- TearSolutions, Inc. funding round, February 2020: $1.5m
TearSolutions November 2024 Series B Funding Round
$3m
TearSolutions, Inc. funding round, February 2020
$1.5m
Industries
TearSolutions is active in the following industries: